NCT06352554View on ClinicalTrials.gov

Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

January 30, 2025

Conditions
DiagnosisGonorrheaResistance Bacterial
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

collaborator

Wellcome Trust

OTHER

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Australian Research Council Research Hub to Combat Antimicrobial Resistance

UNKNOWN

lead

SpeeDx Pty Ltd

INDUSTRY

NCT06352554 - Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections | Biotech Hunter | Biotech Hunter